News & Views
Partnership to Develop Studies on Diabetes and Kidney Disease
Jun 26 2015
AstraZeneca is collaborating with the French National Institute of Health and Medical Research (Inserm) on a three-year project to investigate new therapeutic approaches to type 2 diabetes and Chronic Kidney Disease (CKD). The aim of the collaboration is to advance understanding of the biological mechanisms that underpin these conditions and develop new treatments based on this knowledge.
Under the terms of the collaboration, each project will comprise a joint team of investigators that will work across Inserm sites in Toulouse and Paris, and AstraZeneca’s research hub in Mölndal, Sweden.
The collaboration will focus on three areas: Understanding mineralocorticoid receptor (MR) activity as a route to treating CKD; Enhancing tissue sensitivity to insulin; Exploring loss of insulin production.
Marcus Schindler, Head of Cardiovascular and Metabolic Diseases Innovative Medicines unit, AstraZeneca said: “Over the last few years AstraZeneca has been focusing on pioneering research into cardiovascular and metabolic disease. By joining forces with Professors Langin, Jaisser and Scharfmann and their eminent research groups at Inserm, we strengthen further this ambition because their focus represents an ideal fit with our research strategy.”
Professor Christian Boitard, Director of the Inserm institute for Physiopathology, Metabolism and Nutrition, said: “This collaboration is focusing our efforts in beta cells, mineralocorticoid receptor and lipids handling by tissues. Combining the AstraZeneca and Inserm scientists, expertise and platforms represents a great opportunity for advancing research in these important fields, with the operational support of Inserm Transfert teams.”
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK